Medtronic Launches Simplera Sync CGM Sensor in South Korea, Streamlining Glucose Management for MiniMed 780G Users

August 9, 2026

KBR South Korea

Overview

Medtronic has launched its Simplera Sync Sensor, a new continuous glucose monitoring (CGM) device, in South Korea for users of the MiniMed 780G automated insulin delivery (AID) system. This all-in-one disposable sensor simplifies insertion to just two steps and is approximately half the size of previous Medtronic sensors. It eliminates the need for routine fingerstick calibrations and additional adhesive tape, significantly reducing the burden of glucose management for Type 1 diabetes patients.

In Depth

Key Findings

Medtronic has introduced its latest continuous glucose monitoring (CGM) device, the Simplera Sync Sensor, to the South Korean market for users of the MiniMed 780G automated insulin delivery (AID) system. This innovative sensor dramatically enhances patient convenience in glucose management through a simplified two-step insertion process and a significantly smaller design, approximately half the size of previous Medtronic sensors.

Technical/Clinical Details

The Simplera Sync Sensor is engineered as an all-in-one disposable unit, eliminating the need for routine fingerstick calibrations and supplementary adhesive tape that were typically required with earlier Medtronic CGM sensors. This offers patients a more seamless and less stressful experience in glucose monitoring. Fully integrated with the MiniMed 780G system, the sensor provides continuous real-time glucose data to support automated insulin adjustments, aiming to minimize glucose fluctuations and maximize time in range for patients. Its small, discreet design also improves wearing comfort in daily life, contributing to a better quality of life (QoL) for individuals with diabetes.

Background & Context

In diabetes management, CGM technology has become an indispensable tool, enabling comprehensive understanding of glucose fluctuations and improving patients’ self-management capabilities. However, the complexity of sensor insertion and the necessity for calibrations have posed barriers to adoption for some patients. Medtronic’s Simplera Sync Sensor addresses these challenges with a user-friendly design, aiming to enhance the accessibility and adherence of CGM technology. The launch in South Korea is part of Medtronic’s strategy to strengthen its leadership in global diabetes care solutions.

Strategic Significance & Outlook

The introduction of the Simplera Sync Sensor signifies a further shift in the paradigm of diabetes management, allowing patients to manage their glucose levels more easily and effectively. This type of technological innovation is expected to not only improve the QoL for Type 1 diabetes patients but also potentially boost CGM adoption among insulin-using Type 2 diabetes patients. Future developments are anticipated to focus on even smaller, longer-lasting, and entirely non-invasive CGM technologies, further simplifying diabetes management.

Source: https://www.koreabiomed.com/news/articleView.html?idxno=32632

Get our weekly technology intelligence — free

Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.

Subscribe Free — Weekly Tech Intelligence

By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.